This statistic displays the percentage of select reasons for utilizing direct-to-patient (DTP) distribution methods in the global clinical trial supplies market in 2016. According to the survey, 38 percent of respondents indicated that by using DTP they improved patient retention by increasing convenience.
Reasons for utilizing direct-to-patient distribution methods in the global clinical trial supplies market in 2016
Sums may not add up to exactly 100 percent due to rounding.
* The survey was conducted among industry experts from clinical operations, clinical trial supply logistics and packaging, as well as biopharma manufacturing and supply chain organizations, representing organizations from over 20 countries and clinical supply operations worldwide.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Sonoco. (March 3, 2017). Reasons for utilizing direct-to-patient distribution methods in the global clinical trial supplies market in 2016 [Graph]. In Statista. Retrieved November 10, 2024, from https://www-statista-com.ezproxy.canberra.edu.au/statistics/754850/reasons-for-using-direct-to-patient-distribution-in-clinical-trials/
Sonoco. "Reasons for utilizing direct-to-patient distribution methods in the global clinical trial supplies market in 2016." Chart. March 3, 2017. Statista. Accessed November 10, 2024. https://www-statista-com.ezproxy.canberra.edu.au/statistics/754850/reasons-for-using-direct-to-patient-distribution-in-clinical-trials/
Sonoco. (2017). Reasons for utilizing direct-to-patient distribution methods in the global clinical trial supplies market in 2016. Statista. Statista Inc.. Accessed: November 10, 2024. https://www-statista-com.ezproxy.canberra.edu.au/statistics/754850/reasons-for-using-direct-to-patient-distribution-in-clinical-trials/
Sonoco. "Reasons for Utilizing Direct-to-patient Distribution Methods in The Global Clinical Trial Supplies Market in 2016." Statista, Statista Inc., 3 Mar 2017, https://www-statista-com.ezproxy.canberra.edu.au/statistics/754850/reasons-for-using-direct-to-patient-distribution-in-clinical-trials/
Sonoco, Reasons for utilizing direct-to-patient distribution methods in the global clinical trial supplies market in 2016 Statista, https://www-statista-com.ezproxy.canberra.edu.au/statistics/754850/reasons-for-using-direct-to-patient-distribution-in-clinical-trials/ (last visited November 10, 2024)
Reasons for utilizing direct-to-patient distribution methods in the global clinical trial supplies market in 2016 [Graph], Sonoco, March 3, 2017. [Online]. Available: https://www-statista-com.ezproxy.canberra.edu.au/statistics/754850/reasons-for-using-direct-to-patient-distribution-in-clinical-trials/
